I am also looking forward to the conference. They need to get the first TNBC person injected or the BLA filed. Nothing like knowing positive news is possibly coming out soon of the control of the company to help the share price. The market is evaluating leronlimab--TNBC at 0 right now. With good initial results, that could jump very quickly, as we know good results with unmet need in cancer can expedite the approval, with many interested parties wanting in on the action.

Many on ihub are underestimating just how fast things could change with good TNBC results, because we are been mired down for years with no action.. I believe psychologist call it 'learned helplessness', which many there have now.